Palmitoylethanolamide Reduces Proinflammatory Markers in Unvaccinated Adults Recently Diagnosed with COVID-19: A Randomized Controlled Trial
Article
[키워드] adhesion molecules
age
anti-inflammatory effect
Antigen
assigned
baseline
Biomarker
Blood
BMI
C-reactive protein
CDC
chronic condition
coin toss
Concentration
conducted
Controlled
coronavirus disease
covariates
COVID-19
COVID-19 complications
COVID-19, SARS-COV-2
Cytokines
diagnosed with COVID-19
Diagnosis
dietary supplements
double-blind
dysregulated immune response
Effect
exacerbate
ferritin
group
Health
IL-1β
IL-2
IL-6
implicated
indicated
individual
infected with COVID-19
infections
infectious conditions
Inflammation
inflammatory mediator
intercellular
Linear regression model
mechanism
Multiple
outcomes
P-selectin
palmitoylethanolamide
participant
Placebo
placebo tablet
positive test result
Primary outcome
produced
proinflammatory
promote
randomized placebo-controlled trial
Randomly
receive
reduced
reported
RT-PCR
secretion
severity
Sex
significantly
stratified
treatment effect
[DOI] 10.1093/jn/nxac154 PMC 바로가기
[DOI] 10.1093/jn/nxac154 PMC 바로가기